Spinal Anesthesia With Articaine and Bupivacaine for Outpatient Lower Limb Surgery
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the trial is to compare two local anesthetics, articaine and bupivacaine for outpatient lower limb surgery. Onset and recovery times of sensory and motor blockade will be compared.
| Condition | Intervention | Phase |
|---|---|---|
|
Spinal Anesthesia |
Drug: spinal administration of articaine Drug: spinal administration of bupivacaine |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | Spinal Anesthesia With 5% Articaine and 0.5% Bupivacaine for Outpatient Lower Limb Surgery. A Double-Blind Randomised Clinical Trial |
- recovery time from motor blockade
- onset of sensory and motor blockade
- maximum spread of sensory blockade (30 min after spinal injection of anesthetic)
- spread of sensory blockade after 1,5 hour
- recovery time from sensory blockade
- time to micturation
- complications
| Estimated Enrollment: | 80 |
| Study Start Date: | May 2006 |
| Study Completion Date: | January 2007 |
The purpose of the trial is to compare two local anesthetics, articaine and bupivacaine for outpatient lower limb surgery.
Faster onset and shorter elimination time favours a short-acting local anaesthetic for spinal anesthesia for out-patient lower limb surgery, e.g. knee arthroscopy, foot and varices surgery. Patients will recover faster and less complications will be expected.
Articaine is said to act faster and shorter than a low dose of bupivacaine. There are not enough data available to establish that articaine is as safe as and more effective by outpatient lower limb surgery than bupivacaine.
Spinal anesthesia with articaine will be compared to spinal anesthesia with bupivacaine in a randomized double blind clinical trial.
Endpoints are:
- onset of sensory and motor block
- maximum spread of sensory level
- recovery from sensory and motor block
- time to micturition
- complications
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age between 18 and 70 years
- Patients planned for an outpatient lower limb surgery
- Procedure under spinal anesthesia
- Informed consent
Exclusion Criteria:
- Contra-indications spinal anesthesia
- History of allergic reactions on amide-type local anesthetics
- Length < 1.60 m or > 1.90 m
- BMI < 18.5 kg/m2 or > 35 kg/m2
- Pregnancy
Contacts and Locations
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00332735 History of Changes |
| Other Study ID Numbers: | METC-nr 06-010 |
| Study First Received: | May 31, 2006 |
| Last Updated: | April 18, 2007 |
| Health Authority: | The Netherlands: Medical Ethics Committee South-West Holland The Netherlands: central committee of human related investigation |
Keywords provided by Reinier de Graaf Groep:
|
spinal anesthesia articaine bupivacaine |
outpatient surgery limbs |
Additional relevant MeSH terms:
|
Anesthetics Bupivacaine Carticaine Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Central Nervous System Agents Therapeutic Uses Anesthetics, Local Sensory System Agents Peripheral Nervous System Agents |
ClinicalTrials.gov processed this record on May 19, 2013